Pier 88 Investment Partners LLC grew its stake in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 76.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 20,590 shares of the biopharmaceutical company’s stock after acquiring an additional 8,910 shares during the […]
Ultragenyx Pharmaceutical (NASDAQ:RARE – Get Free Report) announced its quarterly earnings results on Thursday. The biopharmaceutical company reported ($2.03) earnings per share for the quarter, missing analysts’ consensus estimates of ($1.72) by ($0.31), Briefing.com reports. Ultragenyx Pharmaceutical had a negative net margin of 138.58% and a negative return on equity of 421.88%. The business had […]
Royal Bank of Canada began coverage on shares of Ultragenyx Pharmaceutical (NASDAQ:RARE – Free Report) in a report released on Monday, Marketbeat.com reports. The brokerage issued an outperform rating and a $77.00 price target on the biopharmaceutical company’s stock. Several other equities analysts have also recently commented on RARE. JPMorgan Chase & Co. upped their […]
China Universal Asset Management Co. Ltd. raised its position in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 418.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 9,501 shares of the biopharmaceutical company’s stock after acquiring an additional 7,670 shares during the […]
Ultragenyx Pharmaceutical (NASDAQ:RARE) Receives "Overweight" Rating from Cantor Fitzgerald theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.